I agree that this site is using cookies. You can find further informations here.
X
Tsimikas, S.
205  results:
Search for persons X
?
1

Effects of patient characteristics on volanesorsen efficacy..:

Witztum, J.L. ; Gaudet, D. ; Freedman, S....
Atherosclerosis.  355 (2022)  - p. 215 , 2022
Link: https://doi.org/10.1016/..
 
?
2

Inhibition of novel lipoprotein(a) receptor major facilitat..:

Bartoli-Leonard, F ; Rogers, M ; Zheng, K...
Cardiovascular Research.  118 (2022)  Supplement_1 - p. , 2022
Link: https://doi.org/10.1093/..
 
?
3

Interventional hepatic ApoC-III knockdown improves atherosc..:

Gordts, P. ; Ramms, B. ; Pessentheiner, A....
Atherosclerosis.  331 (2021)  - p. e11 , 2021
Link: https://doi.org/10.1016/..
 
?
4

EVALUATION OF THE EFFICACY AND SAFETY OF IONIS-TTR-LRX IN P..:

Maurer, M ; Kristen, A ; Benson, M...
Canadian Journal of Cardiology.  37 (2021)  10 - p. S69 , 2021
Link: https://doi.org/10.1016/..
 
?
5

Prevalence and influence of LPA gene variants and isoform s..:

Tsimikas, S. ; Karwatowska-Prokopczuk, E. ; Clouet-Foraison, N....
Atherosclerosis.  331 (2021)  - p. e114-e115 , 2021
Link: https://doi.org/10.1016/..
 
?
6

Residual inflammatory risk increases endothelial metabolism..:

Hanford, K.M.L. ; Schnitzler, J.G. ; Hoogeveen, R.M....
Atherosclerosis.  331 (2021)  - p. e63-e64 , 2021
Link: https://doi.org/10.1016/..
 
?
7

HDL compartmentalisation regulates PCSK9 activity:

Burnap, S.A. ; Sattler, K. ; Pechlaner, R....
Atherosclerosis.  331 (2021)  - p. e39 , 2021
Link: https://doi.org/10.1016/..
 
?
8

Novel method for quantification of lipoprotein(a)-cholester..:

Yeang, C. ; Su, F. ; Witztum, J.L..
Atherosclerosis.  331 (2021)  - p. e5 , 2021
Link: https://doi.org/10.1016/..
 
?
9

LDL-cholesterol corrected for LP(A)-cholesterol, risk thres..:

Willeit, P. ; Yeang, C. ; Moriarty, P.M....
Atherosclerosis.  315 (2020)  - p. e34-e35 , 2020
Link: https://doi.org/10.1016/..
 
?
10

Atherogenic lipoprotein(A) increases vascular glycolysis, t..:

Schnitzler, J.G. ; Hoogeveen, R.M. ; Ali, L....
Atherosclerosis.  315 (2020)  - p. e10-e11 , 2020
Link: https://doi.org/10.1016/..
 
?
11

Reduction Of Plasma Lipoprotein(A) With Antisense Oligonucl..:

Boffa, M. ; Marar, T. ; Borrelli, M....
Atherosclerosis.  287 (2019)  - p. e59 , 2019
Link: https://doi.org/10.1016/..
 
?
12

Targeting Lipoprotein(A)-Induced Endothelial Cell Metabolic..:

Schnitzler, J. ; Hoogeveen, R. ; Ali, L....
Atherosclerosis.  287 (2019)  - p. e4 , 2019
Link: https://doi.org/10.1016/..
 
?
13

Lipoprotein(A), Oxidized Phospholipids, And Aortic Valve Mi..:

Després, A.A. ; Perrot, N. ; Tastet, L....
Atherosclerosis.  287 (2019)  - p. e110-e111 , 2019
Link: https://doi.org/10.1016/..
 
?
14

Divergent Changes In Lipoprotein(A) And Oxidised Phospholip..:

Ho, J.H. ; Liu, Y. ; Adam, S....
Atherosclerosis.  287 (2019)  - p. e230 , 2019
Link: https://doi.org/10.1016/..
 
?
15

P5322Oxidized phospholipids on apolipoprotein B-100 among b..:

Mefford, M ; Marcovina, S ; Bittner, V...
European Heart Journal.  40 (2019)  Supplement_1 - p. , 2019
Link: https://doi.org/10.1093/..
 
1-15